本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

21.64
+0.49002.32%
盘后21.640.00000.00%18:49 EDT
成交量:391.29万
成交额:8,489.28万
市值:19.29亿
市盈率:-10.82
高:22.24
开:21.36
低:21.19
收:21.15
52周最高:25.29
52周最低:10.64
股本:8,913.87万
流通股本:7,928.57万
量比:1.39
换手率:4.94%
股息:- -
股息率:- -
每股收益(TTM):-1.9993
每股收益(LYR):-4.0759
净资产收益率:-705.73%
总资产收益率:-19.28%
市净率:58.90
市盈率(LYR):-5.31

数据加载中...

2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report